Research and Markets: Oral Cancer - Pipeline Review Q4 2010

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/1a2117/oral_cancer_pipe) has announced the addition of Global Markets Direct's new report "Oral Cancer - Pipeline Review, Q4 2010" to their offering.

“Oral Cancer - Pipeline Review, Q4 2010”

Global Markets Directs, Oral Cancer Pipeline Review, Q4 2010, provides an overview of the Oral Cancer therapeutic pipeline. This report provides information on the therapeutic development for Oral Cancer, complete with latest updates, and special features on late-stage and discontinued projects.

It also reviews key players involved in the therapeutic development for Oral Cancer. Oral Cancer - Pipeline Review 2010, Q4 2010 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Scope:

• A snapshot of the global therapeutic scenario for Oral Cancer.
• A review of the Oral Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Oral Cancer pipeline on the basis of therapeutic class, route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.

Reasons to buy:

• A snapshot of the global therapeutic scenario for Oral Cancer.
• A review of the Oral Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
• Coverage of products based on various stages of development ranging from discovery till registration stages.
• A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
• Coverage of the Oral Cancer pipeline on the basis of therapeutic class, route of administration and molecule type.
• Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
• Key discontinued pipeline projects.
• Latest news and deals relating to the products.

Some Key Topics Covered:

• Global Markets Direct Report Coverage
• Oral Cancer Overview
• Therapeutics Development
• An Overview of Pipeline Products for Oral Cancer
• Oral Cancer Therapeutics under Development by Companies
• Oral Cancer Therapeutics under Investigation by Universities/Institutes
• Companies Involved in Oral Cancer Therapeutics Development
• Pfizer Inc.
• Universities/Institutes Involved in Oral Cancer Therapeutics Development
• Oral Cancer Therapeutics Assessment
• Late Stage Drug Profiles Universities/Institutes
• Panitumumab + Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile
• Product Description
• Mechanism of Action
• R&D Progress
• Tarceva - Drug Profile
• Product Description
• Mechanism of Action
• R&D Progress

For more information visit http://www.researchandmarkets.com/research/1a2117/oral_cancer_pipe